Search research articles
Contact Us
Filters
Showing results (31-40 of 97) with videos related to
Page
of 10
Sort By:
Upsala Journal of Medical Sciences
|
June 23, 2011
Cardiovascular disease risk factors in homeless people
Margit Kaldmäe, Mihkel Zilmer, Margus Viigimaa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 4, 2025
Vascular calcification inhibitors in chronic kidney disease
Annika Adoberg, Liisi Leis, Merike Luman, et al.
Current Pharmaceutical Design
|
February 16, 2019
The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular Disease
Panteleimon Pantelidis, Michail Sideris, Margus Viigimaa, et al.
Blood Pressure
|
May 1, 2010
Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis
Margus Viigimaa, Jelena Abina, Galina Zemtsovskaya, et al.
International Journal of Molecular Sciences
|
July 12, 2025
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
Liudas Vincentas Sinkevicius, Sandra Sakalauskaite, Maris Bukovskis, et al.
BMC Medical Genetics
|
April 12, 2008
N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study
Peeter Juhanson, Katrin Kepp, Elin Org, et al.
Journal of Hypertension
|
July 22, 2010
Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension
George S Stergiou, Martin G Myers, John L Reid, et al.
BMC Cardiovascular Disorders
|
September 2, 2011
HYPEST study: profile of hypertensive patients in Estonia
Elin Org, Gudrun Veldre, Margus Viigimaa, et al.
Medicina (Kaunas, Lithuania)
|
July 26, 2014
Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): results of the Dyslipidemia International Study (DYSIS)
Margus Viigimaa, Andrejs Erglis, Gustavs Latkovskis, et al.
Lipids in Health and Disease
|
November 6, 2010
Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
Margus Viigimaa, Helena Vaverkova, Michel Farnier, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 97) with videos related to
Sort By:
Page
of 10
Upsala Journal of Medical Sciences
|
June 23, 2011
Cardiovascular disease risk factors in homeless people
Margit Kaldmäe, Mihkel Zilmer, Margus Viigimaa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 4, 2025
Vascular calcification inhibitors in chronic kidney disease
Annika Adoberg, Liisi Leis, Merike Luman, et al.
Current Pharmaceutical Design
|
February 16, 2019
The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular Disease
Panteleimon Pantelidis, Michail Sideris, Margus Viigimaa, et al.
Blood Pressure
|
May 1, 2010
Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis
Margus Viigimaa, Jelena Abina, Galina Zemtsovskaya, et al.
International Journal of Molecular Sciences
|
July 12, 2025
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
Liudas Vincentas Sinkevicius, Sandra Sakalauskaite, Maris Bukovskis, et al.
BMC Medical Genetics
|
April 12, 2008
N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study
Peeter Juhanson, Katrin Kepp, Elin Org, et al.
Journal of Hypertension
|
July 22, 2010
Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension
George S Stergiou, Martin G Myers, John L Reid, et al.
BMC Cardiovascular Disorders
|
September 2, 2011
HYPEST study: profile of hypertensive patients in Estonia
Elin Org, Gudrun Veldre, Margus Viigimaa, et al.
Medicina (Kaunas, Lithuania)
|
July 26, 2014
Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): results of the Dyslipidemia International Study (DYSIS)
Margus Viigimaa, Andrejs Erglis, Gustavs Latkovskis, et al.
Lipids in Health and Disease
|
November 6, 2010
Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
Margus Viigimaa, Helena Vaverkova, Michel Farnier, et al.
Page
of 10